|Status : Upcoming||Report Code : VRHC1103||Industry : Healthcare||Available Format :|
Industry Insights by Product (Balloon Sinus Dilation Devices (Standalone Sinus Dilation Procedures and Hybrid Sinus Dilation Procedures), Sinus Stents/Implants, Handheld Instruments, and Endoscopes (Rhinoscopes and Sinuscopes)), by Patient Type (Adult Patients, and Pediatric Patients) and by Patient Care Settings (Hospitals, ENT Clinics/In Office, and Ambulatory Surgical Centers)
Sinusitis is inflammation alongside the sinus lining that advances to nose blockage and further evades mucus drainage. Sinus dilation devices are used to enlarge the sinus openings of nose to deal with drainage issues associated with nasal sinuses or sinusitis. The global sinus dilation devices market is growing at a significant rate, due to the elevated occurrence of chronic sinusitis, and mounting inclination for minimally invasive surgeries.
Different products such as balloon sinus dilation devices, sinus stents/implants, handheld instruments, and endoscopes contributed to the sinus dilation devices market size. The market has witnessed high demand for balloon sinus dilation devices due to the mounting occurrence of chronic sinusitis, escalating focus on the launch of minimally invasive surgical procedures, and mounting inclination for minimally invasive surgical procedures.
Insight by Product
On the basis of product, the market is subdivided into balloon sinus dilation devices, sinus stents/implants, handheld instruments, and endoscopes. Of all products, balloon sinus dilation devices segment accounted the largest share in the market, due to the mounting occurrence of chronic sinusitis, escalating focus on the launch of minimally invasive surgical procedures, and mounting inclination for minimally invasive surgical procedures. Moreover, the sinus stents/implants segment is expected to grow at the fastest rate in the market due to their drug-eluting functionality and decreased scarring and inflammation.
The endoscopes are further subdivided into rhinoscopes and sinuscopes. In addition, the balloon sinus dilation devices are further subdivided into standalone sinus dilation procedures and hybrid sinus dilation procedures.
Insight by Patient Type
On the basis of the patient type the market is subdivided into adult patients, and pediatric patients. The adult patient segment accounted for the larger share in the market as it is more common in adults.
Insight by Patient Care Setting
The different patient care settings of the market are hospitals, ENT clinics/in office, and ambulatory surgical centers. Expanding the number of treatable patients in ENT clinics, cost effectiveness, rapid recovery time, and mounting inclination for minimally invasive techniques are the factors growing the demand of sinus dilation devices in ENT clinics/in office. Among the all patient care settings, the ENT clinics/in office is expected to grow at the fastest rate in the sinus dilation devices market.
In addition, hospitals accounted for the largest share in the market, due to the elevated number of sinus dilation procedures, accessibility of technologically advanced infrastructures, the benefits of having cohesive healthcare amenities, and the capability to execute complicated sinus surgeries.
Elevated occurrence of chronic sinusitis, advantages of balloon sinus dilation above conventional surgeries, and mounting inclination for minimally invasive surgeries are the primary growth drivers for sinus dilation devices market.
Favorable reimbursement scenario, expanding the geriatric population, and technological advancements in sinusitis treatment are also facilitating the growth of the sinus dilation devices market.
Lack of trained otolaryngologists and ENT surgeons, less acceptance of sinus treatment devices, and risks associated with the sinus surgery are the major challenges for the growth of sinus dilation devices market.
Globally, the manufacturing companies trying to enter the sinus dilation devices market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest sinus dilation devices market as in the region the occurrence of chronic sinusitis. In addition, expanding the geriatric population, favorable reimbursement scenario, and elevated implementation of novel technologies among ENT surgeons and otolaryngologists are also up surging growth of the North American sinus dilation devices market.
Asia-Pacific is observed to witness the fastest growth in the market, due to expanding the geriatric population, and a large population base. In addition, the mounting occurrence of chronic sinusitis, the upsurge in disposable income, escalating medical tourism, enhancement in patient alertness about sinus surgical procedures, and mounting inclination for minimally invasive surgeries are also creating a positive impact on the sinus dilation devices market growth in the region.
Key players in the sinus dilation devices market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In December 2017, Stryker Corporation signed an agreement to acquire Entellus Medical, Inc., to provide innovative and cost-effective solutions.
In addition, in July 2016, SinuSys Corporation received FDA clearance for Vent-Os sinus dilation family of devices, for the treatment of treatment of frontal and sphenoid sinuses. Stryker Corporation, Smith & Nephew PLC, SinuSys Corporation, Medtronic Plc., Dalent LLC., Innaccel Pvt. Ltd, Johnson & Johnson, Meril Life Sciences Pvt Ltd., Intersect ENT, Inc., Jilin Coronado Medical Ltd, and Olympus are the key players offering sinus dilation devices.